Twitter | Pretraživanje | |
Mandy Jackson
I am Managing Editor, US Commercial News, for the Informa Pharma Insights publications Scrip and The Pink Sheet. Views expressed here are strictly my own.
16.643
Tweetovi
676
Pratim
4.491
Osobe koje vas prate
Tweetovi
Mandy Jackson proslijedio/la je tweet
a16z 4. velj
We said we'd never do bio. Today, we launched Bio Fund III. Here's why we changed our minds: From a16z Bio general partners:
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 4. velj
CAR-T Yescarta sales flattening out.
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 3. velj
Odgovor korisniku/ci @Jessicaemerrill
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 3. velj
😮🥶🌴☁️💨🌊
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 3. velj
Odgovor korisniku/ci @ByFernandaS @CarinaJulig i 21 ostali
College journalism programs should put more emphasis on business and trade publications. These are also fulfilling journalism jobs and the hours and/or pay generally are better - especially for working parents.
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 31. sij
A lot of new PR pros started following me during . So, a reminder: & only cover drugs, not medical devices or diagnostics, but our colleagues at would love to receive your device & diagnostic news:
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson proslijedio/la je tweet
Odi Bruckman 31. sij
Withdraws European Application of Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 31. sij
“Gilead is working closely with global health authorities to respond to the novel coronavirus (2019-nCoV) outbreak through the appropriate experimental use of our investigational compound remdesivir.”
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 31. sij
Reyvow and Ubrelvy both have launched. Allergan confirmed that its acute drug is available in pharmacies and prescriptions are being filled.
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson proslijedio/la je tweet
Renaissance Capital 31. sij
Arcutis Biotherapeutics prices upsized IPO at $17 high end
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson proslijedio/la je tweet
Renaissance Capital 30. sij
Oncology biotech Black Diamond Therapeutics pops 108% on IPO
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 31. sij
Odgovor korisniku/ci @ScripMandy
“A benefit of ditans, like Lilly’s Reyvow, is that they are not associated with vasoconstriction, which is seen with triptans, making the older drugs contraindicated in patients with cardiovascular disease.” (Subscription required)
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 31. sij
Odgovor korisniku/ci @ScripMandy
Reyvow list price for the on-demand migraine treatment is $640 for a package of 8 tablets (on par with $85/dose for CGRP Ubrelvy).
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 31. sij
Is launching its acute migraine drug Reyvow (lasmiditan) now that it has received DEA scheduling - class V, the lowest potential for abuse.
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 30. sij
Murdo Gordon: Over 92% of commercial lives have access to migraine prevention drug Aimovig with affordable co-pay. More than 80% of prescriptions are paid. Reduction in net selling price in Q1 due to new CVS deal, but stabilizing the rest of the year.
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 30. sij
David Reese pipeline updates in line w/those in this story based on my chat w/the EVP of R&D at about Amgen's efforts to work more efficiently, including through use of genomics, proteomics and transcriptomics (subscription reqd).
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 30. sij
Odgovor korisniku/ci @ScripMandy
All four executives to present - CEO, CFO, EVP commercial and now EVP R&D David Reese - have expressed the company's "enthusiasm for the collaboration with BeiGene"
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 30. sij
Commercial EVP Murdo Gordon notes that Amgen will increase its focus on the psoriasis market now that its has two branded products in this market – Otezla and Enbrel, plus biosimilars.
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 30. sij
CFO Peter Griffith: Net 5% price decline globally in 2019, expect low to mid single-digit net price decline in 2020, which will be more than offset by increased revenue.
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 30. sij
CEO Bob Bradway continues to note, as he did at , that Asia-Pacific will be a major source of growth. Company sees it growing to 25% of its revenue.
Reply Retweet Označi sa "sviđa mi se"